Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet cagrisema is one of the most #potent #weightloss medication developed till date! Cagrisema on an average causes 9% additional weight loss over #semaglutide 2.4mg week! Cagrisema is a fixed dose combination of semaglutide 2.4mg + # Cagrilintide 10mg Valar Peptides Cagrilintide: The Peptide That Makes You Forget About Food. I call it the silence between cravings. Cagrilintide is a long acting amylin analog which means it works alongside leptin and GLP 1 to